| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/02/2010 | US7670602 Concatameric immunoadhesion molecule |
| 03/02/2010 | CA2394615C Substituted 1,3,4-oxadiazoles and a method of reducing tnf-.alpha. levels |
| 02/25/2010 | WO2010022358A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazoio[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 02/25/2010 | WO2010022217A1 Combinations comprising bicyclic s1p lyase inhibitors |
| 02/25/2010 | WO2010022196A2 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase |
| 02/25/2010 | WO2010022043A2 Targeting of histone deacetylase 2 and protein kinase ck2 for treatment of inflammatory diseases |
| 02/25/2010 | WO2010021882A2 Cold menthol receptor antagonists |
| 02/25/2010 | WO2010021797A1 Condensed heterocyclic compounds having 5-ht6 receptor affinity |
| 02/25/2010 | WO2010020762A1 1,5-diaryl-pyrazoles and their use as cannabinoid receptor neutral antagonists |
| 02/25/2010 | WO2010020672A1 Novel phenyl-quinoline-carboxylic acid pyridine derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/25/2010 | WO2010020556A1 New bradykinin b1 antagonists |
| 02/25/2010 | WO2010020521A1 Insceticidal compounds |
| 02/25/2010 | WO2010020379A1 Composition for prevention and treatment of allergic and/or inflammatory diseases |
| 02/25/2010 | WO2010001258A3 Inhibition of tumour growth and metastases |
| 02/25/2010 | WO2010000564A3 Rooibos and inflammation |
| 02/25/2010 | WO2009158571A8 Heteroaryl compounds and uses thereof |
| 02/25/2010 | WO2009158446A3 Crystalline forms of ((((4-((5-(cyclopropylcarbamoyl)-2-methylphenyl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbonyl)(propyl)carbamoyl)oxy)methyl (4-(phosphonooxy)phenyl)acetate, method of preparation and use thereof |
| 02/25/2010 | WO2009146218A8 Compounds including an anti-inflammatory pharmacore and methods of use |
| 02/25/2010 | WO2009143493A3 MODULATORS OF TNFα-DEPENDENT SIGNALING PATHWAYS AND USES THEREOF |
| 02/25/2010 | WO2009129494A4 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation |
| 02/25/2010 | WO2009129205A3 Sparc anti-inflammatory activity and uses thereof |
| 02/25/2010 | WO2009115651A3 N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
| 02/25/2010 | WO2009106752A3 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereof and therapeutic application thereof |
| 02/25/2010 | WO2009106750A3 Derivatives of 6-heterocyclic-imidazo[l,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 02/25/2010 | WO2009101479A3 Fc receptor-binding polypeptides with modified effector functions |
| 02/25/2010 | WO2004092124A8 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 02/25/2010 | US20100048728 Polycyclic dianthraquinones as inhibitors of inflammatory cytokines |
| 02/25/2010 | US20100048727 Perfluoroketone compounds and uses thereof |
| 02/25/2010 | US20100048710 Methods and Compositions for Modulating Muscle Fat in Livestock |
| 02/25/2010 | US20100048702 Prevention of neutrophil recruitment |
| 02/25/2010 | US20100048698 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 02/25/2010 | US20100048663 Substituted Aryl-Indole Compounds and Their Kynurenine/Kynuramine-Like Metabolites As Therapeutic Agents |
| 02/25/2010 | US20100048639 Oxadiazole derivates as s1p1 receptor agonists |
| 02/25/2010 | US20100048635 Use of collismycin and derivatives thereof as oxidative stress inhibitors |
| 02/25/2010 | US20100048633 Piperidine-4-acrylamides |
| 02/25/2010 | US20100048619 Cold Menthol Receptor Antagonists |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | US20100048575 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 02/25/2010 | US20100048568 Pyrimidine hydrazide compounds as pgds inhibitors |
| 02/25/2010 | US20100048565 Benzimidazole derivatives |
| 02/25/2010 | US20100048564 Fused bicyclic heteroaryl derivative |
| 02/25/2010 | US20100048557 Triazolopyridine JAK Inhibitor Compounds and Methods |
| 02/25/2010 | US20100048551 Tricyclic Compounds Useful as Inhibitors of Kinases |
| 02/25/2010 | US20100048549 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 |
| 02/25/2010 | US20100048547 Pi 3-kinase inhibitors and methods of their use |
| 02/25/2010 | US20100048518 Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent |
| 02/25/2010 | US20100048495 Core 2 GlcNAc-T inhibitors III |
| 02/25/2010 | US20100048494 Natural Products from Vinca |
| 02/25/2010 | US20100048492 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 02/25/2010 | US20100048481 Controlled Release Composition |
| 02/25/2010 | US20100047373 Method for Extracting Plants of the Genus Pelargonium, Extract Produced According to Said Method, and Use Thereof |
| 02/25/2010 | US20100047339 Compositions for the treatment of chronic degenerative inflammatory conditions |
| 02/25/2010 | US20100047325 Analgesic anti-inflammatory patches for topical use |
| 02/25/2010 | US20100047236 Antibody variants |
| 02/25/2010 | US20100047196 Novel microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics |
| 02/25/2010 | US20100047179 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 02/25/2010 | US20100047168 Soluble Zcytor 11 Cytokine Receptors |
| 02/25/2010 | CA2771226A1 New bradykinin b1 antagonists |
| 02/25/2010 | CA2735048A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazolo[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 02/25/2010 | CA2734877A1 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase |
| 02/25/2010 | CA2734655A1 Combinations comprising bicyclic s1p lyase inhibitors |
| 02/25/2010 | CA2733160A1 Insecticidal compounds |
| 02/24/2010 | EP2157091A1 Inhibitors of phosphatidylinositol 3-kinase |
| 02/24/2010 | EP2156863A2 Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline reuptake inhibitors |
| 02/24/2010 | EP2155753A1 Substituted imidazopyridazines as pi3k lipid kinase inhibitors |
| 02/24/2010 | EP2155747A1 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors |
| 02/24/2010 | EP2155744A1 Heteroaryl amide analogues as p2x7 antagonists |
| 02/24/2010 | EP2155726A1 Phthalazinone derivatives and their use as medicament to treat cancer |
| 02/24/2010 | EP2155721A1 Organic compounds |
| 02/24/2010 | EP2155715A1 ((phenyl)imidazolyl)methylheteroaryl compounds |
| 02/24/2010 | EP2155712A1 3-(imidazolyl)-pyrazoloý3,4-b¨pyridines |
| 02/24/2010 | EP2155711A1 Substituted benzoylamino-indan-2-carboxylic acids and related compounds |
| 02/24/2010 | EP2155683A2 Pyridone derivatives as p38a mapk inhibitors |
| 02/24/2010 | EP2155678A1 New bradykinin b1 antagonists |
| 02/24/2010 | EP2155666A1 Azetidine derivatives and their use as prostaglandin e2 antagonists |
| 02/24/2010 | EP2155237A2 Method for treatment of cancers or inflammatory diseases |
| 02/24/2010 | EP2155202A2 3,6-disubstituted-imidazo[1,2-b]pyridazines and 3,5-disubstituted pyrazolo[1,5-a]pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 02/24/2010 | EP2155183A1 Amino acid derivatives as calcium channel blockers |
| 02/24/2010 | EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 02/24/2010 | EP1501774B9 Polyunsaturated linear aldehydes and their derivatives with anti-radical activity |
| 02/24/2010 | EP0837696B1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN101653604A Anti-ngf antibodies for the treatment of various disorders |
| 02/24/2010 | CN101653603A Peptides and antibodies binding to anionic phospholipids and aminophospholipids and their use in treating disease |
| 02/24/2010 | CN100591679C Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/24/2010 | CN100591320C Stable surfactant compositions for suspending components |
| 02/23/2010 | USRE41151 Comprising a modified NSAID, wherein the NSAID is covalently attached either directly or through a linker molecule to a sulfur-containing functional group containing an optionally substituted hydrocarbyl moiety; nonsteroidal anti-inflammatory drugs; side-effect reduction |
| 02/23/2010 | USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 02/23/2010 | US7667052 Bioactive substance |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7667007 αvβ3-specific antibodies |
| 02/23/2010 | US7667000 Antibodies to Zcytor 16 |
| 02/23/2010 | US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
| 02/23/2010 | US7666876 Buprenorphine formulations for intranasal delivery |
| 02/23/2010 | US7666867 Heteroindanes: a new class of potent cannabimimetic ligands |
| 02/23/2010 | US7666848 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 02/23/2010 | US7666647 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/23/2010 | US7666624 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 02/23/2010 | US7666422 Methods for the treatment of cancer using anti-CD40 antibodies |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |